<DOC>
	<DOCNO>NCT01465373</DOCNO>
	<brief_summary>The aim study evaluate pharmaceutical therapy advance treatment technique infertile patient require in-vitro fertilization utilize donor egg .</brief_summary>
	<brief_title>Vaginal Progesterone Versus Progesterone Oil Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs</brief_title>
	<detailed_description>The primary objective study evaluate clinical pregnancy rate micronized progesterone ( Endometrin , Ferring Pharmaceuticals ) compare progesterone oil injection in-vitro fertilization ( IVF ) donor egg recipient . The secondary objective evaluate effectiveness freezing/vitrification donor egg . Effectiveness vitrification evaluate egg thaw/survival , fertilization , implantation rate .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Oocyte Donors : Age 2134 year age BMI 1834 Normal ovarian reserve , define FSH &lt; 10 AFC &gt; 10 Medical evaluation consistent FDA criterion donor inclusion Donor Oocyte Recipients Documented history infertility require donor oocyte optimal fertility potential Documentation normal uterine cavity hysteroscopy , hysterosonogram , HSG within 1 year study screen Fresh Frozen Sperm Oocyte Donors : Abnormal ovarian reserve , define FSH &lt; 10 , AFC &gt; 10 , prior poor response control ovarian hyperstimulation ( COHS ) Failure meet FDA criterion donor approval ( risk factor medical evaluation ) Previous history poor response COHS Donor Oocyte Recipients : Uncontrolled hypothyroidism , hyperprolactinemia , systemic disease may interfere study treatment Active thrombophlebitis thromboembolic disorder , history hormone associate thrombophlebitis thromboembolic disorder Surgically aspirate sperm ( TESE ) 2 clinical pregnancy loss ( exclude aneuploidy previous autologous cycle ) Clinically significant gynecologic pathology uterine abnormality , submucosal fibroid &gt; 5 cm , communicate hydrosalpinx , uncorrected uterine septum , undiagnosed vaginal bleeding , endometrial atypia , condition could adversely affect pregnancy outcomes History 2 fail IVF donor cycle</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>In-Vitro Fertilization</keyword>
	<keyword>Donor Egg IVF</keyword>
</DOC>